4-Bromo-1-Methyl-2-Nitrobenzene CAS 60956-26-5 - China Manufacturers, Suppliers, Factory

4-Bromo-1-Methyl-2-Nitrobenzene CAS 60956-26-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-Bromo-2-Nitrotoluene CAS 60956-26-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-Bromo-2-Nitrotoluene CAS 60956-26-5 Purity >98.0% (GC)
Read More

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...

2022.10.30 11:34:39
2022.09.04 00:47:29
2022.08.14 13:48:52
2022.08.11 08:13:19
2022.04.08 10:35:28
2021.12.19 17:06:54

4-Bromo-1-Methyl-2-Nitrobenzene CAS 60956-26-5 - China Manufacturers, Suppliers, Factory

Related Products

4-Bromo-2-Nitrotoluene CAS 60956-26-5 Purity >98.0% (GC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Top Selling Products

3-Chloro-L-Phenylalanine CAS 80126-51-8 Purity >98.0% (HPLC)

5-Bromo-2-Methylindole CAS 1075-34-9 Purity >97.0% High Quality

Indoline CAS 496-15-1 Purity >99.0% (GC) Factory High Quality

Furosemide CAS 54-31-9 Assay ≥99.0% Diuretic API Factory High Quality

Darifenacin Hydrobromide Darifenacin HBr CAS 133099-07-7 Assay ≥99.0% API Factory High Quality

Boc-D-Asparagine CAS 75647-01-7 (Boc-D-Asn-OH) Purity >99.0% (HPLC) Factory

Ac-3,5-Dinitro-Tyr-OH CAS 20767-00-4 Purity >99.0% (HPLC) Factory

Veratroyl Chloride CAS 3535-37-3 3,4-Dimethoxybenzoyl Chloride Purity >98.0% (GC)

2-Bromoallyl Alcohol CAS 598-19-6 Purity >98.5% (GC)

Sodium Triacetoxyborohydride (STAB) CAS 56553-60-7 Purity >98.0% (Titration) Factory

Fmoc-Glu(OMe)-OH CAS 145038-50-2 Purity >98.0% (HPLC)

2,3-Dichloropyrazine CAS 4858-85-9 Purity >98.0% (GC)

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Xi presents award to top scientists

The “Summit on COVID-19 Diagnostics & Treatment”

2022.10.30 11:34:39

2022.09.04 00:47:29

2022.08.14 13:48:52

2022.08.11 08:13:19

2022.04.08 10:35:28

2021.12.19 17:06:54

related search